Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 12 (2%) | |
| Anticipated shortage: | 7 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
82 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2023-12-19 | 2024-01-19 | 213761 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2023-12-13 | 2024-03-25 | 213129 |
| MYLAN-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-11-06 | 2024-03-25 | 209416 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2023-11-14 | 209413 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-10-30 | 2024-03-25 | 208613 |
| VITAMIN C | 500MG | SOLUTION | Actual shortage | 2023-10-17 | 2024-05-10 | 207192 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-17 | 2023-12-19 | 207187 |
| MYLAN-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-10-17 | 2024-05-15 | 207184 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-10-11 | 2023-11-28 | 206781 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-10-03 | 2024-01-10 | 205932 |
| MYLAN-TADALAFIL | 20MG | TABLET | Avoided shortage | 2023-09-20 | 2023-09-26 | 204802 |
| MYLAN-FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-09-11 | 2023-09-26 | 204098 |
| MYLAN-SUMATRIPTAN | 25MG | TABLET | Resolved | 2023-09-11 | 2023-10-11 | 204095 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2023-09-06 | 2023-11-06 | 203708 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2023-09-06 | 2023-12-19 | 203693 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-08-29 | 2023-10-03 | 203214 |
| MYLAN-BECLO AQ | 50MCG | SUSPENSION METERED-DOSE AEROSOL | Resolved | 2023-08-29 | 2024-02-29 | 203100 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-08-16 | 2023-11-06 | 201965 |
| MYLAN-BACLOFEN | 20MG | TABLET | Resolved | 2023-08-16 | 2023-10-25 | 201960 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Avoided shortage | 2023-08-01 | 2023-10-03 | 200648 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
| MYLAN-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6720 |
| MYLAN-PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6717 |
| MYLAN-PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6714 |
| MYLAN-PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6710 |
| MYLAN-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6707 |
| MYLAN-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6704 |
| GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
| GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
| MYLAN-EZETIMIBE | 10MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6695 |
| MYLAN-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6692 |
| MYLAN-METOPROLOL (TYPE L) | 100MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6673 |
| MYLAN-METOPROLOL (TYPE L) | 25MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6670 |
| MYLAN-MEMANTINE | 10MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6667 |